An analysis of the early events when oligodendrocyte precursor cells are triggered to differentiate by thyroid hormone, retinoic acid, or PDGF withdrawal

Developmental Biology

Volumn 213, Issue 2, 1999, Pages 327-339

  Tokumoto, Yasuhito M ^a   Durand, Béatrice ^a   Raff, Martin C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

C fos; Cdk inhibitors; Ceramide galactosyltransferase; D cyclins; Immediate early genes; NGFI A Krox 24; Oligodendrocytes; PDGF; Retinoic acid; Thyroid hormone

Indexed keywords

CERAMIDE; CYCLIN D; CYCLIN E; GALACTOSYLTRANSFERASE; PLATELET DERIVED GROWTH FACTOR; RETINOIC ACID; STRESS ACTIVATED PROTEIN KINASE; THYROID HORMONE;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; STEM CELL;

ANIMALIA;

EID: 0033568239     PISSN: 00121606     EISSN: None     Source Type: Journal    
DOI: 10.1006/dbio.1999.9397     Document Type: Article

References (67)

1. Ahlgren S. C., Wallace H., Bishop J., Neophytou C., Raff M. C. Effect of thyroid hormone on embryonic oligodendrocyte precursor cell development in vivo and in vitro. Mol. Cell. Neurosci. 9:1997;420-432.
2. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochem. Biophys. Acta. 1072:1991;129-157.
3. Bansal R., Warrington A. E., Gard A. L., Ranscht B. Multiple and novel specificities of monoclonal antibodies O1, O4 and R-mAb used in the analysis of oligodendrocyte development. J. Neurosci. Res. 24:1989;548-557.
4. Bansal R., Pfeiffer S. E. Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses to FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev. Biol. 162:1994a;511-524.
5. Bansal R., Pfeiffer S. E. Regulation of gene expression in mature oligodendrocytes by the specialized myelin-like membrane environment: Antibody perturbation in culture with the monoclonal antibody R-mAb. Glia. 12:1994b;173-179.
6. Barres B. A., Hart I. K., Coles H. S.R., Burne J. F., Voyvodic J. T., Richardson W. D., Raff M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
7. Barres B. A., Raff M. C. Control of oligodendrocyte number in the developing rat optic nerve. Neuron. 12:1994;935-942.
8. Barres B. A., Lazar M. A., Raff M. C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 120:1994;1097-1108.
9. Bartkova J., Lukas J., Strauss M., Bartek J. Cyclin D3: Requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene. 17:1998;1027-1037.
10. Bögler O., Noble M. Measurement of time in oligodendrocyte-type-2 astrocyte (O-2A) progenitors is a cellular process distinct from differentiation or division. Dev. Biol. 162:1994;525-538.
11. Bosio A., Binczek E., Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. USA. 93:1996;13280-13285.
12. Bottenstein J. E., Sato G. H. Growth of rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA. 76:1997;514-517.
13. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB J. 10:1996;941-954.
14. Casaccia-Bonnefil P., Tikoo R., Kiyokawa H., Friedrich V. Jr., Chao M. V., Koff A. Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev. 11:1997;2335-2346.
15. Chen J.-Y., Penco S., Ostrowski J., Balaguer P., Pons M., Starret J. E., Reczek P., Chambon P., Gronemeyer H. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation. EMBO J. 14:1995;1187-1197.
16. Coetzee T., Fujita N., Dupree J., Shi R., Blight A., Suzuki Ki., Suzuki Ku., Popko B. Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability. Cell. 86:1996;209-219.
17. Diamond M. I., Miner J. N., Yoshinaga S. K., Yamamoto K. R. Transcription factor interactions: Selectors of positive or negative regulation from a single DNA element. Science. 249:1990;1266-1272.
18. Durand B., Gao F. B., Raff M. Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J. 16:1997;306-317.
19. Durand B., Fero M. L., Roberts J. M., Raff M. C. p27Kip1 alters the response of cells to mitogen and is part of a cell-intrinsic timer that arrests the cell cycle and initiates differentiation. Curr. Biol. 8:1998;431-440.
20. Dussault J. H., Ruel J. Thyroid hormones and brain development. Annu. Rev. Physiol. 49:1987;321-334.
21. Eisenbarth G. S., Walsh F. S., Nirenberg M. Monoclonal antibody to a plasma membrane antigen of neurons. Proc. Natl. Acad. Sci. USA. 76:1979;4913-4917.
22. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
23. Fero M. L., Rivkin M., Tasch M., Porter P., Carow C. E., Firpo E., Polyak K., Tsai L. H., Broudy V., Perlmutter R. M., Kaushansky K., Roberts J. M. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 85:1996;733-744.
24. Figueiredo B. C., Almazan G., Ma Y., Tetzlaff W., Miller F. D., Cuello A. C. Gene expression in the developing cerebellum during perinatal hypo- and hyperthyroidism. Brain Res. Mol. Brain Res. 17:1993;256-268.
25. Franklin D. S., Godfrey V. L., Lee H., Kovalev G. I., Schoonhoven R., Chen-Kiang S., Su L., Xiong Y. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12:1998;2899-2911.
26. Farsetti A., Mitsuhashi T., Desvergne B., Robbins J., Nikodem V. M. Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J. Biol. Chem. 266:1991;23226-23232.
27. Gao F. B., Durand B., Raff M. Oligodendrocyte precursor cells count time but not cell divisions before differentiation. Curr. Biol. 7:1997;152-155.
28. Ibarrola N., Mayer-Pröuschel M., Rodriguez-Pena A., Noble M. Evidence for the existence of at least two timing mechanisms that contribute to oligodendrocyte generation in vitro. Dev. Biol. 180:1996;1-21.
29. Iyer V. R., Eisen M. B., Ross D. T., Schuler G., Moore T., Lee J. F. C., Trent J. M., Staudt L. M., Hudson J. Jr., Boguski M. S., Lashkari D., Shalon D., Botstein D., Brown P. O. The transcription program in the response of human fibroblast to serum. Science. 283:1999;83-87.
30. Jahn L., Sadoshima J.-I., Izumo S. Cyclins and cyclin-dependent kinases are differentially regulated during terminal differentiation of C2C12 mouse cells. Exp. Cell Res. 212:1994;297-307.
31. Johe K. K., Hazel T. G., Muller T., Dugich-Djordjevic M. M., McKay R. D. Single factors direct the differentiation of stem cells from fetal and adult central nervous system. Genes Dev. 10:1996;3129-3140.
32. Johnson R. S., Spiegelman B. R., Papaioannou V. Pleiotropic effects of null mutation in the c-fos proto-oncogene. Cell. 71:1992;577-586.
33. Karin M., Liu Z.-G., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
34. Kerppola T. K., Luk D., Curran T. Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol. Cell. Biol. 13:1993;3782-3791.
35. Kiess M., Gill R. M., Hamel P. A. Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes. Oncogene. 10:1995;159-166.
36. Kiyokawa H., Kineman R. D., Manova-Todorova K. O., Soares V. C., Hoffman E. S., Ono M., Khanam D., Hayday A. C., Frohman L. A., Koff A. Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 85:1996;721-732.
37. Legrand J. Thyroid hormone effects on growth and development. Hennemann G. Thyroid Hormone Metabolism. 1986;503-534 Dekker, New York.
38. Lillien L. E., Raff M. C. Differentiation signals in the CNS: Type-2 astrocyte development in vitro as a model system. Neuron. 5:1990;111-119.
39. Lopez-Barahona L., Minano M., Mira E., Iglesias T., Stunnenberg H. G., Rodoriguez-Pena A., Bernal J., Munoz A. Retinoic acid posttranscriptionally up-regulates proteolipid protein gene expression in C6 glioma cells. J. Biol. Chem. 268:1993;25617-25623.
40. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: The second decade. Cell. 83:1995;835-839.
41. Nakayama K., Ishida N., Shirane M., Inomata A., Inoue T., Shishido N., Horii I., Loh D. Y. Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumours. Cell. 85:1996;707-720.
42. Nicholson R. C., Mader S., Nagpal S., Leid M., Rochette-Egly C., Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J. 9:1990;4443-4454.
43. Noble M., Murray K., Stroobant P., Waterfield M. D., Riddle P. Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature. 333:1988;560-562.
44. Quelle D. E., Zindy F., Ashmun R. A., Sherr C. J. Alternative reading frames of the INK4a tumour suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell. 83:1995;993-1000.
45. Raff M. C., Mirsky R., Fields K. L., Lisak R. P., Dorfman S. H., Silberberg D. H., Gregson N. A., Leibowitz S., Kennedy M. C. Galactocerebroside is a specific cell-surface antigenic marker for oligodendrocytes in culture. Nature. 274:1978;813-816.
46. Raff M. C., Miller R. H., Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature. 303:1983;390-396.
47. Raff M. C., Lillien L. E., Richardson W. D., Burne J. F., Noble M. D. Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature. 333:1988;562-565.
48. Raff M. C., Durand B., Gao F.-B. Cell number control and timing in animal development: The oligodendrocyte cell lineage. Int. J. Dev. Biol. 42:1998;263-267.
49. Ranscht B., Clapshaw P. A., Price J., Noble M., Seifert W. Development of oligodendrocytes and schwann cells studied with a monoclonal antibody against galactocerebroside. Proc. Natl. Acad. Sci. USA. 79:1982;2709-2713.
50. Ransone L. J., Verma I. M. Nuclear proto-oncogene fos and jun. Annu. Rev. Cell Biol. 6:1990;539-557.
51. Rao S. S., Kohtz D. S. Positive and negative regulation of D-type cyclin expression in skeltal myoblasts by basic fibroblast growth factor and transforming growth factor β J. Biol. Chem. 270:1995;4093-4100.
52. Riabowol K., Schiff J., Gilman M. Z. Transcription factor AP-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc. Natl. Acad. Sci. USA. 89:1992;157-161.
53. Richardson W. D., Pringle N., Mosley M. J., Westermark B., Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 53:1988;309-319.
54. Rodriguez-Pena A., Ibarrola N., Iniguez M. A., Munoz A., Bernal J. Neonatal hypothyroidism affects the timely expression of myelin-associated glycoprotein in the rat brain. J. Clin. Invest. 91:1993;812-818.
55. Sherr C. J., Roberts J. M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
56. Schüle R., Rangarajan P., Yang N., Kliewer S., Ransone L. J., Bolado J., Verma I. M., Evans R. M. Retinoic acid is a negative regulator of AP-1-responsive genes. Proc. Natl. Acad. Sci. USA. 88:1991;6092-6096.
57. Schulte S., Stoffel W. Ceramide UDP galactosyltransferase from myelinating rat brain: Purification, cloning, and expression. Proc. Natl. Acad. Sci. USA. 90:1993;10265-10267.
58. Shanker G., Pieringer R. A. Investigations on myelinogenesis in vitro: II. The occurrence and regulation of protein kinases by thyroid hormone in primary cultures of cells dissociated from embryonic mouse brain. Biosci. Rep. 7:1987;159-165.
59. Sock E., Leger H., Kuhlbrodt K., Schreiber J., Enderich J., Richter-Landsberg C., Wegner M. Expression of Krox proteins during differentiation of the O-2A progenitor cell line CG-4. J. Neurochem. 68:1997;1911-1919.
60. Sommer I., Schachner M. monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev. Biol. 83:1981;311-327.
61. Temple S., Raff M. C. Clonal analysis of oligodendrocyte development in culture: Evidence for developmental clock that counts cell divisions. Cell. 44:1986;773-779.
62. Tosic M., Torch S., Comte V., Dolivo M., Honegger P., Matthieu J. M. Triiodothyronine has diverse and multiple stimulating effects on expression of the major myelin protein genes. J. Neurochem. 59:1992;1770-1777.
63. Walters S. N., Morell P. Effect of altered thyroid states on myelinogenesis. J. Neurochem. 36:1981;1792-1801.
64. Wang Z., Brown D. D. Thyroid hormone-induced gene expression program for amphibian tail resorption. J. Biol. Chem. 268:1993;16270-16278.
65. Wang Z.-Q., Ovitt C., Gringoridadius A. E., Möhle-Steinlein U., Rüther U., Wangner E. F. Bone and haematopoietic defects in mice lacking c-fos. Nature. 360:1992;741-745.
66. Yang-Yen H.-F., Chambard J.-C., Sun Y.-L., Smeal T., Schmidt T. J., Drouin J., Karin M. Transcription interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell. 62:1990;1205-1215.
67. Zhang X.-K., Wills K. N., Husmann M., Hermann T., Pfahl M. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol. Cell. Biol. 11:1991;6016-6025.